Caribou says it’s cracked ‘off-the-shelf’ cell therapy, but needs to raise money to move forwardnews2025-11-03T12:00:16+00:00November 3rd, 2025|Endpoints News|
Roche, Manifold Bio to advance new brain shuttles in pact worth up to $2B+news2025-11-03T11:45:30+00:00November 3rd, 2025|Endpoints News|
BioNTech ups sales guidance after Bristol Myers’ bispecific paymentnews2025-11-03T11:45:21+00:00November 3rd, 2025|Endpoints News|
Amgen Ventures joins $141M Series B for Italian gene therapy biotech AAVantgardenews2025-11-03T08:00:27+00:00November 3rd, 2025|Endpoints News|
Tidmarsh’s exit at FDA pushes an agency in transition further toward instabilitynews2025-11-03T02:48:10+00:00November 3rd, 2025|Endpoints News|
FDA drug head Tidmarsh is put on leave, according to reportsnews2025-11-02T22:13:53+00:00November 2nd, 2025|Endpoints News|
Novo makes a play for Metsera; This week’s other big deal; Earnings in full swing; and morenews2025-11-01T10:00:55+00:00November 1st, 2025|Endpoints News|
Pfizer sues to stop Novo’s Metsera takeover attemptnews2025-10-31T20:41:12+00:00October 31st, 2025|Endpoints News|
Hawaii federal judge rules against FDA decision to maintain abortion pill restrictions news2025-10-31T19:27:00+00:00October 31st, 2025|Endpoints News|
Baby KJ researchers publish FDA interactions as agency eyes new pathwaynews2025-10-31T19:14:34+00:00October 31st, 2025|Endpoints News|
